{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:22:21Z","timestamp":1793323341064,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00198-015-3377-6","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T04:29:42Z","timestamp":1446438582000},"page":"1441-1450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study"],"prefix":"10.1007","volume":"27","author":[{"given":"K.","family":"Sumida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Imafuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Takaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"issue":"3","key":"3377_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ndtplus\/sfn040","volume":"1","author":"VM Brandenburg","year":"2008","unstructured":"Brandenburg VM, Floege J (2008) Adynamic bone disease-bone and beyond. NDT plus 1(3):135\u2013147. doi: 10.1093\/ndtplus\/sfn040","journal-title":"NDT plus"},{"issue":"6","key":"3377_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36(6):1115\u20131121. doi: 10.1053\/ajkd.2000.19812","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3377_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10157-011-0502-5","volume":"15","author":"H Komaba","year":"2011","unstructured":"Komaba H, Kakuta T, Fukagawa M (2011) Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol 15(6):797\u2013809. doi: 10.1007\/s10157-011-0502-5","journal-title":"Clin Exp Nephrol"},{"issue":"19","key":"3377_CR4","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434\u20131441. doi: 10.1056\/NEJM200105103441904","journal-title":"N Engl J Med"},{"issue":"9","key":"3377_CR5","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1210\/jc.2011-3479","volume":"97","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M (2012) Randomized teriparatide [human parathyroid hormone (PTH) 1\u201334] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97(9):3097\u20133106. doi: 10.1210\/jc.2011-3479","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3377_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000316708","volume":"33","author":"D Cejka","year":"2010","unstructured":"Cejka D, Kodras K, Bader T, Haas M (2010) Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study. Kidney Blood Press Res 33(3):221\u2013226. doi: 10.1159\/000316708","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"3377_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000341864","volume":"36","author":"E Mitsopoulos","year":"2012","unstructured":"Mitsopoulos E, Ginikopoulou E, Economidou D, Zanos S, Pateinakis P, Minasidis E, Memmos D, Thodis E, Vargemezis V, Tsakiris D (2012) Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study. Am J Nephrol 36(3):238\u2013244. doi: 10.1159\/000341864","journal-title":"Am J Nephrol"},{"issue":"2","key":"3377_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ckj\/sfv005","volume":"8","author":"P Giamalis","year":"2015","unstructured":"Giamalis P, Economidou D, Dimitriadis C, Memmos D, Papagianni A, Efstratiadis G (2015) Treatment of adynamic bone disease in a haemodialysis patient with teriparatide. Clin Kidney J 8(2):188\u2013190. doi: 10.1093\/ckj\/sfv005","journal-title":"Clin Kidney J"},{"issue":"6","key":"3377_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","volume":"65","author":"P Palcu","year":"2015","unstructured":"Palcu P, Dion N, Ste-Marie LG, Goltzman D, Radziunas I, Miller PD, Jamal SA (2015) Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report. Am J Kidney Dis 65(6):933\u2013936. doi: 10.1053\/j.ajkd.2015.01.025","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3377_CR10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/ki.1990.144","volume":"37","author":"T Sugimoto","year":"1990","unstructured":"Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E (1990) Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int 37(6):1522\u20131527","journal-title":"Kidney Int"},{"issue":"4","key":"3377_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.jrn.2009.10.006","volume":"20","author":"R Dukkipati","year":"2010","unstructured":"Dukkipati R, Kovesdy CP, Colman S, Budoff MJ, Nissenson AR, Sprague SM, Kopple JD, Kalantar-Zadeh K (2010) Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 20(4):243\u2013254. doi: 10.1053\/j.jrn.2009.10.006","journal-title":"J Ren Nutr"},{"issue":"4","key":"3377_CR12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.V341008","volume":"3","author":"ER Gagne","year":"1992","unstructured":"Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C, Drueke TB (1992) Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 3(4):1008\u20131017","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3377_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1046\/j.1523-1755.2000.00222.x","volume":"58","author":"E Slatopolsky","year":"2000","unstructured":"Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58(2):753\u2013761. doi: 10.1046\/j.1523-1755.2000.00222.x","journal-title":"Kidney Int"},{"issue":"4","key":"3377_CR14","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","volume":"58","author":"ML Picton","year":"2000","unstructured":"Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, Gokal R, Hoyland JA (2000) Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58(4):1440\u20131449. doi: 10.1046\/j.1523-1755.2000.00306.x","journal-title":"Kidney Int"},{"issue":"9","key":"3377_CR15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","volume":"20","author":"Y Iwasaki-Ishizuka","year":"2005","unstructured":"Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M (2005) Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 20(9):1904\u20131911. doi: 10.1093\/ndt\/gfh876","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3377_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","volume":"39","author":"JJ Kazama","year":"2002","unstructured":"Kazama JJ, Shigematsu T, Yano K, Tsuda E, Miura M, Iwasaki Y, Kawaguchi Y, Gejyo F, Kurokawa K, Fukagawa M (2002) Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 39(3):525\u2013532. doi: 10.1053\/ajkd.2002.31402","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3377_CR17","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","volume":"21","author":"Y Iwasaki","year":"2006","unstructured":"Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A, Motojima M, Fukagawa M (2006) Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats. Nephrol Dial Transplant 21(10):2768\u20132774. doi: 10.1093\/ndt\/gfl311","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"3377_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.ki.5002097","volume":"71","author":"T Nii-Kono","year":"2007","unstructured":"Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M, Yamato H, Kurokawa K, Fukagawa M (2007) Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71(8):738\u2013743. doi: 10.1038\/sj.ki.5002097","journal-title":"Kidney Int"},{"issue":"4 Suppl 1","key":"3377_CR19","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1053\/ajkd.2001.27428","volume":"38","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto T, Ozono K, Miyauchi A, Kasayama S, Kojima Y, Shima M, Okada S (2001) Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am J Kidney Dis 38(4 Suppl 1):S161\u2013S164","journal-title":"Am J Kidney Dis"},{"key":"3377_CR20","doi-asserted-by":"crossref","unstructured":"Hampl H, Steinmuller T, Frohling P, Naoum C, Leder K, Stabell U, Schnoy N, Jehle PM (1999) Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner Electrolyte Metab 25 (3):161\u2013170. doi:57440","DOI":"10.1159\/000057440"},{"issue":"11","key":"3377_CR21","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1002\/jbmr.126","volume":"25","author":"A Yajima","year":"2010","unstructured":"Yajima A, Inaba M, Tominaga Y, Nishizawa Y, Ikeda K, Ito A (2010) Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism. J Bone Miner Res 25(11):2374\u20132381. doi: 10.1002\/jbmr.126","journal-title":"J Bone Miner Res"},{"issue":"4","key":"3377_CR22","first-page":"192","volume":"39","author":"M Kaye","year":"1993","unstructured":"Kaye M, Rosenthall L, Hill RO, Tabah RJ (1993) Long-term outcome following total parathyroidectomy in patients with end-stage renal disease. Clin Nephrol 39(4):192\u2013197","journal-title":"Clin Nephrol"},{"issue":"11","key":"3377_CR23","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1210\/jcem.83.11.5249","volume":"83","author":"M Abdelhadi","year":"1998","unstructured":"Abdelhadi M, Nordenstrom J (1998) Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 83(11):3845\u20133851. doi: 10.1210\/jcem.83.11.5249","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3377_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1440-1797.2009.01257.x","volume":"15","author":"HW Chan","year":"2010","unstructured":"Chan HW, Chu KH, Fung SK, Tang HL, Lee W, Cheuk A, Yim KF, Tong MK, Lee KC (2010) Prospective study on dialysis patients after total parathyroidectomy without autoimplant. Nephrology (Carlton) 15(4):441\u2013447. doi: 10.1111\/j.1440-1797.2009.01257.x","journal-title":"Nephrology (Carlton)"},{"issue":"8","key":"3377_CR25","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1681\/ASN.2007010022","volume":"18","author":"KD Rudser","year":"2007","unstructured":"Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B (2007) Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 18(8):2401\u20132407. doi: 10.1681\/ASN.2007010022","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3377_CR26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/jbmr.305","volume":"26","author":"ML Frost","year":"2011","unstructured":"Frost ML, Siddique M, Blake GM, Moore AE, Schleyer PJ, Dunn JT, Somer EJ, Marsden PK, Eastell R, Fogelman I (2011) Differential effects of teriparatide on regional bone formation using (18)F-fluoride positron emission tomography. J Bone Miner Res 26(5):1002\u20131011. doi: 10.1002\/jbmr.305","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3377_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00198-010-1226-1","volume":"22","author":"HM Macdonald","year":"2011","unstructured":"Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK (2011) Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int 22(1):357\u2013362. doi: 10.1007\/s00198-010-1226-1","journal-title":"Osteoporos Int"},{"issue":"12","key":"3377_CR28","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s00198-012-1955-4","volume":"23","author":"D Michalska","year":"2012","unstructured":"Michalska D, Luchavova M, Zikan V, Raska I Jr, Kubena AA, Stepan JJ (2012) Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Osteoporos Int 23(12):2885\u20132891. doi: 10.1007\/s00198-012-1955-4","journal-title":"Osteoporos Int"},{"issue":"3","key":"3377_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","volume":"47","author":"A Miyauchi","year":"2010","unstructured":"Miyauchi A, Matsumoto T, Sugimoto T, Tsujimoto M, Warner MR, Nakamura T (2010) Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone 47(3):493\u2013502. doi: 10.1016\/j.bone.2010.05.022","journal-title":"Bone"},{"issue":"4","key":"3377_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s001980050151","volume":"9","author":"T Fujita","year":"1999","unstructured":"Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, Takahashi HE, Yamamoto K, Fukunaga M (1999) Effect of an intermittent weekly dose of human parathyroid hormone (1\u201334) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int 9(4):296\u2013306. doi: 10.1007\/s001980050151","journal-title":"Osteoporos Int"},{"issue":"3","key":"3377_CR31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00198-013-2516-1","volume":"25","author":"T Sugimoto","year":"2014","unstructured":"Sugimoto T, Nakamura T, Nakamura Y, Isogai Y, Shiraki M (2014) Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis. Osteoporos Int 25(3):1173\u20131180. doi: 10.1007\/s00198-013-2516-1","journal-title":"Osteoporos Int"},{"issue":"1\u20132","key":"3377_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2152\/jmi.62.93","volume":"62","author":"T Enishi","year":"2015","unstructured":"Enishi T, Uemura H, Katoh S, Inatsugi M, Minato S, Inatsugi K, Inatsugi M, Sato N, Siryo K (2015) Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient: a case report and insight for the drug interaction between hypotensive agents and teriparatide. J Med Invest 62(1\u20132):93\u201396. doi: 10.2152\/jmi.62.93","journal-title":"J Med Invest"},{"issue":"4","key":"3377_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1210\/edrv-10-4-420","volume":"10","author":"LL Mok","year":"1989","unstructured":"Mok LL, Nickols GA, Thompson JC, Cooper CW (1989) Parathyroid hormone as a smooth muscle relaxant. Endocr Rev 10(4):420\u2013436. doi: 10.1210\/edrv-10-4-420","journal-title":"Endocr Rev"},{"issue":"4","key":"3377_CR34","first-page":"665","volume":"84","author":"AD Care","year":"1999","unstructured":"Care AD, Abbas SK, Harmeyer J, Boivin R (1999) The relaxant effects of parathyroid hormone(1\u201334) and parathyroid hormone-related protein(1\u201334) on ovine reticulo-ruminal smooth muscle in vivo. Exp Physiol 84(4):665\u2013675","journal-title":"Exp Physiol"},{"issue":"Suppl 2","key":"3377_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2362.2006.01666.x","volume":"36","author":"C Schwarz","year":"2006","unstructured":"Schwarz C, Sulzbacher I, Oberbauer R (2006) Diagnosis of renal osteodystrophy. Eur J Clin Invest 36(Suppl 2):13\u201322. doi: 10.1111\/j.1365-2362.2006.01666.x","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"3377_CR36","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1093\/oxfordjournals.ndt.a027210","volume":"11","author":"A Gerakis","year":"1996","unstructured":"Gerakis A, Hutchison AJ, Apostolou T, Freemont AJ, Billis A (1996) Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transplant 11(12):2430\u20132438","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"3377_CR37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","volume":"26","author":"Q Qi","year":"1995","unstructured":"Qi Q, Monier-Faugere MC, Geng Z, Malluche HH (1995) Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26(4):622\u2013631","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3377_CR38","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1046\/j.1442-2042.2001.00340.x","volume":"8","author":"A Yajima","year":"2001","unstructured":"Yajima A, Ogawa Y, Ikehara A, Tominaga T, Inou T, Otsubo O (2001) Development of low-turnover bone diseases after parathyroidectomy and autotransplantation. Int J Urol 8(8):S76\u2013S79","journal-title":"Int J Urol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3377-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3377-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3377-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3377-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T19:57:59Z","timestamp":1653422279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3377-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3377"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3377-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}